Demographic, clinical and laboratory characteristics of studied subjects according to hospitalization need
| Patients’ characteristics . | Total n (%) . | Hospitalization n (%) . | Non-hospitalization n (%) . |
|---|---|---|---|
| 5233 (100) | 3533 (67.5) | 1700 (32.5) | |
| Demographic characteristics | |||
| Age categories | |||
| <18 | 5 (0.1) | 5 (0.1) | 0 (0) |
| 18–49 (average: 36) | 2308 (45) | 986 (28) | 1322 (80.7) |
| 50–64 (average: 57) | 1423 (27.5) | 1156 (32.8) | 267 (16.3) |
| >65 (average: 74) | 1424 (27.6) | 1371 (39) | 49 (3) |
| NA | 73 (1.4) | 11 (0.3) | 62 (3.8) |
| Sex | |||
| Female | 2838 (54) | 1626 (46) | 1212 (71.4) |
| Male | 2391 (45.8) | 1906 (54) | 485 (28.6) |
| NA | 4 (0.1) | 1 (0.02) | 3 (0.2) |
| Ethic | |||
| White | 3409 (66) | 2453 (70.8) | 956 (56.2) |
| Brown | 1183 (23) | 684 (19.7) | 499 (29.4) |
| Black | 445 (8.6) | 244 (7) | 201 (11.8) |
| Native Brazilian | 5 (0.1) | 1 (0.02) | 4 (0.2) |
| Asian | 69 (1.3) | 39 (1.1) | 30 (1.8) |
| Other | 6 (0.1) | 4 (0.1) | 2 (0.1) |
| NA | 69 (1.3) | 69 (2) | 0 (0) |
| Health characteristics | |||
| Hypertension | 2185 (42) | 1937 (55.3) | 248 (14.7) |
| Cardiovascular D | 1021 (20) | 996 (29.6) | 25 (1.5) |
| ACEi users | 431 (9.5) | 395 (13.7) | 36 (2.2) |
| Asthma | 239 (4.6) | 172 (4.9) | 67 (4) |
| Tabagism | 1002 (19.4) | 833 (24) | 169 (10) |
| COPD | 219 (4.2) | 213 (6.1) | 6 (0.4) |
| Diabetes mellitus type 2 | 1329 (25.7) | 1238 (35.4) | 91 (5.4) |
| HIV | 35 (0.7) | 33 (0.9) | 2 (0.1) |
| CKD | 449 (8.7) | 441 (12.6) | 8 (0.5) |
| BMI status | |||
| Obese (BMI of 30 kg/m2 or greater) | 1186 (32.2) | 735 (36.4) | 447 (26.8) |
| Overweight (BMI of 25–29.9 kg/m2) | 1341 (36.4) | 683 (33.8) | 659 (39.6) |
| Normal (BMI of 20–24.9 kg/m2) | 984 (26.7) | 489 (24.2) | 496 (29.8) |
| BMI of 20 kg/m2 or lower | 176 (4.8) | 113 (5.6) | 63 (3.8) |
| NA | 1529 (29.6) | 1514 (42.8) | 35 (2.1) |
| Oncologic | 191 (3.7) | 170 (4.9) | 21 (1.2) |
| Autoimmune diseases | 132 (2.6) | 101 (2.9) | 31 (1.8) |
| Case severity | |||
| Hospitalization | 3533 (67.5) | 3533 (100) | 0 (0) |
| ICU | 2186 (41.8) | 2186 (62.6) | 0 (0) |
| Oxygen | 2621 (50.1) | 2619 (75.1) | 2 (0.1) |
| No-invasive ventilation | 1263 (24.1) | 1263 (36.2) | 0 (0) |
| Mechanical ventilation | 1521 (29.1) | 1521 (43.6) | 0 (0) |
| Dialysis | 511 (9.8) | 511 (14.8) | 0 (0) |
| Vaccination status | |||
| Yes (2 doses) | 856 (16.4) | 60 (1.7) | 796 (46.8) |
| Yes (1 dose) | 102 (1.9) | 58 (1.6) | 44 (2.6) |
| No | 4275 (81.7) | 3415 (96.7) | 860 (50.6) |
| Patients’ characteristics . | Total n (%) . | Hospitalization n (%) . | Non-hospitalization n (%) . |
|---|---|---|---|
| 5233 (100) | 3533 (67.5) | 1700 (32.5) | |
| Demographic characteristics | |||
| Age categories | |||
| <18 | 5 (0.1) | 5 (0.1) | 0 (0) |
| 18–49 (average: 36) | 2308 (45) | 986 (28) | 1322 (80.7) |
| 50–64 (average: 57) | 1423 (27.5) | 1156 (32.8) | 267 (16.3) |
| >65 (average: 74) | 1424 (27.6) | 1371 (39) | 49 (3) |
| NA | 73 (1.4) | 11 (0.3) | 62 (3.8) |
| Sex | |||
| Female | 2838 (54) | 1626 (46) | 1212 (71.4) |
| Male | 2391 (45.8) | 1906 (54) | 485 (28.6) |
| NA | 4 (0.1) | 1 (0.02) | 3 (0.2) |
| Ethic | |||
| White | 3409 (66) | 2453 (70.8) | 956 (56.2) |
| Brown | 1183 (23) | 684 (19.7) | 499 (29.4) |
| Black | 445 (8.6) | 244 (7) | 201 (11.8) |
| Native Brazilian | 5 (0.1) | 1 (0.02) | 4 (0.2) |
| Asian | 69 (1.3) | 39 (1.1) | 30 (1.8) |
| Other | 6 (0.1) | 4 (0.1) | 2 (0.1) |
| NA | 69 (1.3) | 69 (2) | 0 (0) |
| Health characteristics | |||
| Hypertension | 2185 (42) | 1937 (55.3) | 248 (14.7) |
| Cardiovascular D | 1021 (20) | 996 (29.6) | 25 (1.5) |
| ACEi users | 431 (9.5) | 395 (13.7) | 36 (2.2) |
| Asthma | 239 (4.6) | 172 (4.9) | 67 (4) |
| Tabagism | 1002 (19.4) | 833 (24) | 169 (10) |
| COPD | 219 (4.2) | 213 (6.1) | 6 (0.4) |
| Diabetes mellitus type 2 | 1329 (25.7) | 1238 (35.4) | 91 (5.4) |
| HIV | 35 (0.7) | 33 (0.9) | 2 (0.1) |
| CKD | 449 (8.7) | 441 (12.6) | 8 (0.5) |
| BMI status | |||
| Obese (BMI of 30 kg/m2 or greater) | 1186 (32.2) | 735 (36.4) | 447 (26.8) |
| Overweight (BMI of 25–29.9 kg/m2) | 1341 (36.4) | 683 (33.8) | 659 (39.6) |
| Normal (BMI of 20–24.9 kg/m2) | 984 (26.7) | 489 (24.2) | 496 (29.8) |
| BMI of 20 kg/m2 or lower | 176 (4.8) | 113 (5.6) | 63 (3.8) |
| NA | 1529 (29.6) | 1514 (42.8) | 35 (2.1) |
| Oncologic | 191 (3.7) | 170 (4.9) | 21 (1.2) |
| Autoimmune diseases | 132 (2.6) | 101 (2.9) | 31 (1.8) |
| Case severity | |||
| Hospitalization | 3533 (67.5) | 3533 (100) | 0 (0) |
| ICU | 2186 (41.8) | 2186 (62.6) | 0 (0) |
| Oxygen | 2621 (50.1) | 2619 (75.1) | 2 (0.1) |
| No-invasive ventilation | 1263 (24.1) | 1263 (36.2) | 0 (0) |
| Mechanical ventilation | 1521 (29.1) | 1521 (43.6) | 0 (0) |
| Dialysis | 511 (9.8) | 511 (14.8) | 0 (0) |
| Vaccination status | |||
| Yes (2 doses) | 856 (16.4) | 60 (1.7) | 796 (46.8) |
| Yes (1 dose) | 102 (1.9) | 58 (1.6) | 44 (2.6) |
| No | 4275 (81.7) | 3415 (96.7) | 860 (50.6) |
Abbreviations: ACEi, angiotensin-converting enzyme inhibitors; BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; ICU, intensive care unit; NA, not available.
Demographic, clinical and laboratory characteristics of studied subjects according to hospitalization need
| Patients’ characteristics . | Total n (%) . | Hospitalization n (%) . | Non-hospitalization n (%) . |
|---|---|---|---|
| 5233 (100) | 3533 (67.5) | 1700 (32.5) | |
| Demographic characteristics | |||
| Age categories | |||
| <18 | 5 (0.1) | 5 (0.1) | 0 (0) |
| 18–49 (average: 36) | 2308 (45) | 986 (28) | 1322 (80.7) |
| 50–64 (average: 57) | 1423 (27.5) | 1156 (32.8) | 267 (16.3) |
| >65 (average: 74) | 1424 (27.6) | 1371 (39) | 49 (3) |
| NA | 73 (1.4) | 11 (0.3) | 62 (3.8) |
| Sex | |||
| Female | 2838 (54) | 1626 (46) | 1212 (71.4) |
| Male | 2391 (45.8) | 1906 (54) | 485 (28.6) |
| NA | 4 (0.1) | 1 (0.02) | 3 (0.2) |
| Ethic | |||
| White | 3409 (66) | 2453 (70.8) | 956 (56.2) |
| Brown | 1183 (23) | 684 (19.7) | 499 (29.4) |
| Black | 445 (8.6) | 244 (7) | 201 (11.8) |
| Native Brazilian | 5 (0.1) | 1 (0.02) | 4 (0.2) |
| Asian | 69 (1.3) | 39 (1.1) | 30 (1.8) |
| Other | 6 (0.1) | 4 (0.1) | 2 (0.1) |
| NA | 69 (1.3) | 69 (2) | 0 (0) |
| Health characteristics | |||
| Hypertension | 2185 (42) | 1937 (55.3) | 248 (14.7) |
| Cardiovascular D | 1021 (20) | 996 (29.6) | 25 (1.5) |
| ACEi users | 431 (9.5) | 395 (13.7) | 36 (2.2) |
| Asthma | 239 (4.6) | 172 (4.9) | 67 (4) |
| Tabagism | 1002 (19.4) | 833 (24) | 169 (10) |
| COPD | 219 (4.2) | 213 (6.1) | 6 (0.4) |
| Diabetes mellitus type 2 | 1329 (25.7) | 1238 (35.4) | 91 (5.4) |
| HIV | 35 (0.7) | 33 (0.9) | 2 (0.1) |
| CKD | 449 (8.7) | 441 (12.6) | 8 (0.5) |
| BMI status | |||
| Obese (BMI of 30 kg/m2 or greater) | 1186 (32.2) | 735 (36.4) | 447 (26.8) |
| Overweight (BMI of 25–29.9 kg/m2) | 1341 (36.4) | 683 (33.8) | 659 (39.6) |
| Normal (BMI of 20–24.9 kg/m2) | 984 (26.7) | 489 (24.2) | 496 (29.8) |
| BMI of 20 kg/m2 or lower | 176 (4.8) | 113 (5.6) | 63 (3.8) |
| NA | 1529 (29.6) | 1514 (42.8) | 35 (2.1) |
| Oncologic | 191 (3.7) | 170 (4.9) | 21 (1.2) |
| Autoimmune diseases | 132 (2.6) | 101 (2.9) | 31 (1.8) |
| Case severity | |||
| Hospitalization | 3533 (67.5) | 3533 (100) | 0 (0) |
| ICU | 2186 (41.8) | 2186 (62.6) | 0 (0) |
| Oxygen | 2621 (50.1) | 2619 (75.1) | 2 (0.1) |
| No-invasive ventilation | 1263 (24.1) | 1263 (36.2) | 0 (0) |
| Mechanical ventilation | 1521 (29.1) | 1521 (43.6) | 0 (0) |
| Dialysis | 511 (9.8) | 511 (14.8) | 0 (0) |
| Vaccination status | |||
| Yes (2 doses) | 856 (16.4) | 60 (1.7) | 796 (46.8) |
| Yes (1 dose) | 102 (1.9) | 58 (1.6) | 44 (2.6) |
| No | 4275 (81.7) | 3415 (96.7) | 860 (50.6) |
| Patients’ characteristics . | Total n (%) . | Hospitalization n (%) . | Non-hospitalization n (%) . |
|---|---|---|---|
| 5233 (100) | 3533 (67.5) | 1700 (32.5) | |
| Demographic characteristics | |||
| Age categories | |||
| <18 | 5 (0.1) | 5 (0.1) | 0 (0) |
| 18–49 (average: 36) | 2308 (45) | 986 (28) | 1322 (80.7) |
| 50–64 (average: 57) | 1423 (27.5) | 1156 (32.8) | 267 (16.3) |
| >65 (average: 74) | 1424 (27.6) | 1371 (39) | 49 (3) |
| NA | 73 (1.4) | 11 (0.3) | 62 (3.8) |
| Sex | |||
| Female | 2838 (54) | 1626 (46) | 1212 (71.4) |
| Male | 2391 (45.8) | 1906 (54) | 485 (28.6) |
| NA | 4 (0.1) | 1 (0.02) | 3 (0.2) |
| Ethic | |||
| White | 3409 (66) | 2453 (70.8) | 956 (56.2) |
| Brown | 1183 (23) | 684 (19.7) | 499 (29.4) |
| Black | 445 (8.6) | 244 (7) | 201 (11.8) |
| Native Brazilian | 5 (0.1) | 1 (0.02) | 4 (0.2) |
| Asian | 69 (1.3) | 39 (1.1) | 30 (1.8) |
| Other | 6 (0.1) | 4 (0.1) | 2 (0.1) |
| NA | 69 (1.3) | 69 (2) | 0 (0) |
| Health characteristics | |||
| Hypertension | 2185 (42) | 1937 (55.3) | 248 (14.7) |
| Cardiovascular D | 1021 (20) | 996 (29.6) | 25 (1.5) |
| ACEi users | 431 (9.5) | 395 (13.7) | 36 (2.2) |
| Asthma | 239 (4.6) | 172 (4.9) | 67 (4) |
| Tabagism | 1002 (19.4) | 833 (24) | 169 (10) |
| COPD | 219 (4.2) | 213 (6.1) | 6 (0.4) |
| Diabetes mellitus type 2 | 1329 (25.7) | 1238 (35.4) | 91 (5.4) |
| HIV | 35 (0.7) | 33 (0.9) | 2 (0.1) |
| CKD | 449 (8.7) | 441 (12.6) | 8 (0.5) |
| BMI status | |||
| Obese (BMI of 30 kg/m2 or greater) | 1186 (32.2) | 735 (36.4) | 447 (26.8) |
| Overweight (BMI of 25–29.9 kg/m2) | 1341 (36.4) | 683 (33.8) | 659 (39.6) |
| Normal (BMI of 20–24.9 kg/m2) | 984 (26.7) | 489 (24.2) | 496 (29.8) |
| BMI of 20 kg/m2 or lower | 176 (4.8) | 113 (5.6) | 63 (3.8) |
| NA | 1529 (29.6) | 1514 (42.8) | 35 (2.1) |
| Oncologic | 191 (3.7) | 170 (4.9) | 21 (1.2) |
| Autoimmune diseases | 132 (2.6) | 101 (2.9) | 31 (1.8) |
| Case severity | |||
| Hospitalization | 3533 (67.5) | 3533 (100) | 0 (0) |
| ICU | 2186 (41.8) | 2186 (62.6) | 0 (0) |
| Oxygen | 2621 (50.1) | 2619 (75.1) | 2 (0.1) |
| No-invasive ventilation | 1263 (24.1) | 1263 (36.2) | 0 (0) |
| Mechanical ventilation | 1521 (29.1) | 1521 (43.6) | 0 (0) |
| Dialysis | 511 (9.8) | 511 (14.8) | 0 (0) |
| Vaccination status | |||
| Yes (2 doses) | 856 (16.4) | 60 (1.7) | 796 (46.8) |
| Yes (1 dose) | 102 (1.9) | 58 (1.6) | 44 (2.6) |
| No | 4275 (81.7) | 3415 (96.7) | 860 (50.6) |
Abbreviations: ACEi, angiotensin-converting enzyme inhibitors; BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; ICU, intensive care unit; NA, not available.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
